179 related articles for article (PubMed ID: 29119051)
1. USP51 promotes deubiquitination and stabilization of ZEB1.
Zhou Z; Zhang P; Hu X; Kim J; Yao F; Xiao Z; Zeng L; Chang L; Sun Y; Ma L
Am J Cancer Res; 2017; 7(10):2020-2031. PubMed ID: 29119051
[TBL] [Abstract][Full Text] [Related]
2. CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism.
Zhang Z; Li J; Ou Y; Yang G; Deng K; Wang Q; Wang Z; Wang W; Zhang Q; Wang H; Sun W; Sun P; Yang S
Signal Transduct Target Ther; 2020 Mar; 5(1):25. PubMed ID: 32296027
[TBL] [Abstract][Full Text] [Related]
3. CDK4/6-USP51 axis regulates lung adenocarcinoma metastasis through ZEB1.
Li J; Xiao X; Wang H; Wang W; Ou Y; Wang Z; Jiang H; Liu Y; Zhang Z; Yang S
Cancer Gene Ther; 2022 Aug; 29(8-9):1181-1192. PubMed ID: 35058607
[TBL] [Abstract][Full Text] [Related]
4. USP51/ZEB1/ACTA2 axis promotes mesenchymal phenotype in gastric cancer and is associated with low cohesion characteristics.
Liu YJ; Zeng SH; Zhang W; Li JP; Yin Y; Zhuang YW; Zhou JY; Liu SL; Zou X
Pharmacol Res; 2023 Feb; 188():106644. PubMed ID: 36603607
[TBL] [Abstract][Full Text] [Related]
5. USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A.
Mu M; Zhang Q; Li J; Zhao C; Li X; Chen Z; Sun X; Yu J
Cell Death Differ; 2023 Nov; 30(11):2393-2407. PubMed ID: 37816999
[TBL] [Abstract][Full Text] [Related]
6. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
Kong X; Ding X; Li X; Gao S; Yang Q
Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin.
Kim J; Alavi Naini F; Sun Y; Ma L
Am J Cancer Res; 2018; 8(9):1823-1836. PubMed ID: 30323974
[TBL] [Abstract][Full Text] [Related]
8. USP37 is a SNAI1 deubiquitinase.
Xiao Z; Chang L; Kim J; Zhang P; Hang Q; Yap S; Guo Y; Zhou Z; Zeng L; Hu X; Siverly A; Sun Y; Ma L
Am J Cancer Res; 2019; 9(12):2749-2759. PubMed ID: 31911859
[TBL] [Abstract][Full Text] [Related]
9. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
10. ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance.
Hashimoto A; Hashimoto S; Sugino H; Yoshikawa A; Onodera Y; Handa H; Oikawa T; Sabe H
Oncogenesis; 2016 Sep; 5(9):e259. PubMed ID: 27617643
[TBL] [Abstract][Full Text] [Related]
11. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
[TBL] [Abstract][Full Text] [Related]
12. YEATS4 is associated with poor prognosis and promotes epithelial-to-mesenchymal transition and metastasis by regulating ZEB1 expression in breast cancer.
Li Y; Li L; Wu J; Qin J; Dai X; Jin T; Xu J
Am J Cancer Res; 2021; 11(2):416-440. PubMed ID: 33575079
[TBL] [Abstract][Full Text] [Related]
13. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
[TBL] [Abstract][Full Text] [Related]
14. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
15. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
16. HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer.
Zhang W; Shi X; Peng Y; Wu M; Zhang P; Xie R; Wu Y; Yan Q; Liu S; Wang J
PLoS One; 2015; 10(6):e0129603. PubMed ID: 26057751
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17-induced EMT promotes lung cancer cell migration and invasion via NF-κB/ZEB1 signal pathway.
Gu K; Li MM; Shen J; Liu F; Cao JY; Jin S; Yu Y
Am J Cancer Res; 2015; 5(3):1169-79. PubMed ID: 26045995
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
Wang M; Zhang R; Zhang S; Xu R; Yang Q
Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines.
Orellana-Serradell O; Herrera D; Castellon EA; Contreras HR
Asian J Androl; 2018; 20(3):294-299. PubMed ID: 29271397
[TBL] [Abstract][Full Text] [Related]
20. FAT4-USP51 complex regulates the proliferation and invasion of endometrial cancer via Hippo pathway.
Che X; Jian F; Jia N; Zheng Y; Jiang Y; Feng W
Am J Transl Res; 2019; 11(5):2784-2800. PubMed ID: 31217854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
